22q11.2 duplication syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:1727OMIM:608363Q92.3
Who is this for?
Show terms as
1Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

22q11.2 duplication syndrome is a rare chromosomal disorder caused by a microduplication of a region on the long arm of chromosome 22 (band 11.2). This is the reciprocal genomic rearrangement of the well-known 22q11.2 deletion syndrome (DiGeorge/velocardiofacial syndrome). The duplicated region typically spans approximately 3 megabases and encompasses multiple genes, including TBX1. The condition is also referred to as 22q11.2 microduplication syndrome. Because the clinical presentation is highly variable, some individuals carrying the duplication may have no apparent symptoms, which complicates diagnosis and genetic counseling. The syndrome can affect multiple body systems, though with incomplete penetrance and variable expressivity. Key clinical features may include intellectual disability or learning difficulties (often mild to moderate), developmental delay, speech and language delays, growth retardation, and behavioral abnormalities. Congenital heart defects have been reported in some patients, though less frequently than in the deletion syndrome. Velopharyngeal insufficiency, palatal abnormalities, and urogenital anomalies may also occur. Some individuals present with dysmorphic facial features, which can be subtle and may include hypertelorism, a broad flat nasal bridge, and micrognathia. Hypotonia in infancy is also described. There is no specific cure for 22q11.2 duplication syndrome. Management is symptomatic and supportive, tailored to the individual's clinical presentation. This may include speech therapy, occupational therapy, educational support, cardiac evaluation and management if heart defects are present, and behavioral or psychiatric interventions as needed. Genetic counseling is recommended for affected families, as the duplication can be inherited from a mildly affected or apparently unaffected parent. Regular developmental monitoring is important, particularly in childhood, to ensure early intervention for any emerging difficulties.

Also known as:

Clinical phenotype terms— hover any for plain English:

Abnormality of the pharynxHP:0000600
Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for 22q11.2 duplication syndrome.

View clinical trials →

No actively recruiting trials found for 22q11.2 duplication syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the 22q11.2 duplication syndrome community →

Specialists

1 foundView all specialists →
FM
Frank Ong, MD
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to 22q11.2 duplication syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open 22q11.2 duplication syndromeForum →

No community posts yet. Be the first to share your experience with 22q11.2 duplication syndrome.

Start the conversation →

Latest news about 22q11.2 duplication syndrome

No recent news articles for 22q11.2 duplication syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about 22q11.2 duplication syndrome

What is 22q11.2 duplication syndrome?

22q11.2 duplication syndrome is a rare chromosomal disorder caused by a microduplication of a region on the long arm of chromosome 22 (band 11.2). This is the reciprocal genomic rearrangement of the well-known 22q11.2 deletion syndrome (DiGeorge/velocardiofacial syndrome). The duplicated region typically spans approximately 3 megabases and encompasses multiple genes, including TBX1. The condition is also referred to as 22q11.2 microduplication syndrome. Because the clinical presentation is highly variable, some individuals carrying the duplication may have no apparent symptoms, which complicat

How is 22q11.2 duplication syndrome inherited?

22q11.2 duplication syndrome follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

Which specialists treat 22q11.2 duplication syndrome?

1 specialists and care centers treating 22q11.2 duplication syndrome are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.